Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements - Summary of Reconciliation of Statements of Cash Flows (Detail)

v3.21.1
Restatement of Previously Issued Financial Statements - Summary of Reconciliation of Statements of Cash Flows (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Cash Flows from Operating Activities:        
Net income (loss)     $ (2,398,841) $ 5,094,479
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Gain on marketable securities, dividends and interest held in Trust Account $ (86,803) $ (1,561,854) (1,201,382) (3,322,448)
Gain on revaluation of warrant liability 1,106,250 951,250 2,278,750 (2,666,250)
General and administrative expenses paid by related party       2,206
Gain on marketable securities, dividends and interest held in Trust Account     (1,201,382) (3,322,448)
Changes in operating assets and liabilities:        
Prepaid expenses     15,654 (101,988)
Accounts payable     284,630 79,620
Accrued expenses     405,711 (87,694)
Net cash used in operating activities     (615,478) (1,002,075)
Cash Flows from Investing Activities:        
Cash deposited in Trust Account       (287,500,000)
Net cash used in investing activities       (287,500,000)
Cash Flows from Financing Activities:        
Proceeds from note payable to related party       250,000
Repayment of note payable and advances from related party       (252,206)
Proceeds received from initial public offering       287,500,000
Proceeds from private placement       7,750,000
Offering costs paid       (5,151,990)
Net cash provided by financing activities       290,095,804
Net change in cash     (615,478) 1,593,729
Cash - beginning of period     1,589,795 25,000
Cash - end of period 974,317 1,618,729 974,317 1,618,729
Supplemental disclosure of noncash activities:        
Offering costs included in accrued expenses     0 85,000
Offering costs included in accounts payable     0 2,600
Remeasurement of ordinary shares subject to possible redemption       26,789,590
Deferred underwritting commissions       9,187,500
Restatement Adjustment        
Cash Flows from Operating Activities:        
Net income (loss)     (2,278,750) 2,018,011
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Gain on revaluation of warrant liability     2,278,750 (2,666,250)
Changes in operating assets and liabilities:        
Net cash used in operating activities       (648,239)
Cash Flows from Financing Activities:        
Offering costs paid       648,239
Net cash provided by financing activities       648,239
Supplemental disclosure of noncash activities:        
Remeasurement of ordinary shares subject to possible redemption     120,090 (251,483,850)
Deferred underwritting commissions       9,187,500
As Reported        
Cash Flows from Operating Activities:        
Net income (loss)     (120,091) 3,076,468
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Gain on marketable securities, dividends and interest held in Trust Account (86,803) (1,561,854) (1,201,382) (3,322,448)
General and administrative expenses paid by related party       2,206
Gain on marketable securities, dividends and interest held in Trust Account       (3,322,448)
Changes in operating assets and liabilities:        
Prepaid expenses     15,654 (101,988)
Accounts payable     284,630 79,620
Accrued expenses     405,711 (87,694)
Net cash used in operating activities     (615,478) (353,836)
Cash Flows from Investing Activities:        
Cash deposited in Trust Account       (287,500,000)
Net cash used in investing activities       (287,500,000)
Cash Flows from Financing Activities:        
Proceeds from note payable to related party       250,000
Repayment of note payable and advances from related party       (252,206)
Proceeds received from initial public offering       287,500,000
Proceeds from private placement       7,750,000
Offering costs paid       (5,800,229)
Net cash provided by financing activities       289,447,565
Net change in cash     (615,478) 1,593,729
Cash - beginning of period     1,589,795 25,000
Cash - end of period $ 974,317 $ 1,618,729 974,317 1,618,729
Supplemental disclosure of noncash activities:        
Offering costs included in accrued expenses     0 85,000
Offering costs included in accounts payable     0 2,600
Remeasurement of ordinary shares subject to possible redemption     $ (120,090) $ 278,273,440